{"log_id": 1052399927491309962, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 0.000411, "average": 0.987294, "min": 0.952185}, "location": {"width": 91, "top": 312, "height": 34, "left": 322}, "words": "【禁忌】"}, {"probability": {"variance": 0.014244, "average": 0.934121, "min": 0.531177}, "location": {"width": 557, "top": 354, "height": 43, "left": 365}, "words": "禁用于已知对伊曲康唑及本品任一轴料过敏的患者"}, {"probability": {"variance": 3.1e-05, "average": 0.992036, "min": 0.986512}, "location": {"width": 70, "top": 358, "height": 36, "left": 1427}, "words": "国家"}, {"probability": {"variance": 0.00639, "average": 0.961999, "min": 0.737141}, "location": {"width": 408, "top": 408, "height": 38, "left": 365}, "words": "禁用于不能注射氯化钠注射液的患者"}, {"probability": {"variance": 0, "average": 0.999893, "min": 0.999893}, "location": {"width": 36, "top": 411, "height": 34, "left": 1473}, "words": "药"}, {"probability": {"variance": 0.005095, "average": 0.966578, "min": 0.596404}, "location": {"width": 1014, "top": 445, "height": 57, "left": 365}, "words": "羟丙基一一环糊精是通过肾小球滤过清除,因此严重肾功能损伤的患者(1酐清除"}, {"probability": {"variance": 0.017709, "average": 0.917794, "min": 0.568621}, "location": {"width": 237, "top": 513, "height": 31, "left": 372}, "words": "c30ml/min)禁用本品"}, {"probability": {"variance": 0.000439, "average": 0.989718, "min": 0.934673}, "location": {"width": 207, "top": 566, "height": 36, "left": 367}, "words": "禁与下列药物合用"}, {"probability": {"variance": 0.011979, "average": 0.929442, "min": 0.594838}, "location": {"width": 989, "top": 600, "height": 54, "left": 370}, "words": "可引起订T间期延长的CYP3A4代谢底物,例如特非那丁、阿司咪唑、咪唑斯汀、苄普地尔"}, {"probability": {"variance": 0.017982, "average": 0.93958, "min": 0.363072}, "location": {"width": 1016, "top": 650, "height": 54, "left": 367}, "words": "西沙必利,多非利特、左醋美沙朵(左美沙酮)、尼丁,匹莫齐特、舍吲哚、上述药物"}, {"probability": {"variance": 0.011746, "average": 0.959972, "min": 0.492915}, "location": {"width": 1014, "top": 701, "height": 57, "left": 370}, "words": "与本品合用时,可能会使这些底物的血浆浓度升高,导致如间期延长及尖端迅转型室的"}, {"probability": {"variance": 0.000336, "average": 0.98313, "min": 0.952151}, "location": {"width": 105, "top": 772, "height": 29, "left": 370}, "words": "罕见发生"}, {"probability": {"variance": 0.014868, "average": 0.924781, "min": 0.484693}, "location": {"width": 737, "top": 806, "height": 52, "left": 367}, "words": "经CYP3A4代谢的HMG一CoA还原酶抑制剂,如他汀或辛伐他打"}, {"probability": {"variance": 0.040212, "average": 0.863108, "min": 0.436509}, "location": {"width": 253, "top": 870, "height": 31, "left": 370}, "words": "三唑仑和口咪达唑仑"}, {"probability": {"variance": 0.030922, "average": 0.897928, "min": 0.409513}, "location": {"width": 689, "top": 906, "height": 52, "left": 367}, "words": "麦角生物碱,如双氢角按、角新碱、麦角肢、甲麦角新碱"}, {"probability": {"variance": 3.4e-05, "average": 0.993725, "min": 0.98764}, "location": {"width": 107, "top": 970, "height": 34, "left": 370}, "words": "尼索地平"}, {"probability": {"variance": 0.008851, "average": 0.95537, "min": 0.661664}, "location": {"width": 358, "top": 1014, "height": 45, "left": 370}, "words": "除危及生命的病例,禁用于孕妇"}, {"probability": {"variance": 0.001656, "average": 0.985644, "min": 0.762533}, "location": {"width": 867, "top": 1052, "height": 54, "left": 370}, "words": "育龄妇女使用本品时,应采取适当的避孕措施,直至停药后的下一个月经周期"}, {"probability": {"variance": 0, "average": 0.984771, "min": 0.984771}, "location": {"width": 100, "top": 1100, "height": 54, "left": 1171}, "words": "药"}, {"probability": {"variance": 7.2e-05, "average": 0.995416, "min": 0.976502}, "location": {"width": 141, "top": 1171, "height": 31, "left": 328}, "words": "【注意事项】"}, {"probability": {"variance": 0, "average": 0.98628, "min": 0.98628}, "location": {"width": 194, "top": 1144, "height": 43, "left": 1130}, "words": "A"}, {"probability": {"variance": 0, "average": 0.702489, "min": 0.702489}, "location": {"width": 31, "top": 1183, "height": 29, "left": 1260}, "words": "色"}, {"probability": {"variance": 0.003347, "average": 0.972315, "min": 0.820349}, "location": {"width": 205, "top": 1219, "height": 34, "left": 376}, "words": "对心脏方面的影响"}, {"probability": {"variance": 0, "average": 0.720682, "min": 0.720682}, "location": {"width": 73, "top": 1201, "height": 38, "left": 1272}, "words": "芒"}, {"probability": {"variance": 0.01378, "average": 0.92416, "min": 0.519669}, "location": {"width": 1023, "top": 1242, "height": 70, "left": 370}, "words": "在使用伊曲康唑注射液的健康志愿者中,观察到有一过性、无法软的室射血分降此"}, {"probability": {"variance": 0.022136, "average": 0.932637, "min": 0.381063}, "location": {"width": 1071, "top": 1297, "height": 66, "left": 322}, "words": "现象在下一次注射前自行消失伊康唑显示有负性肌力作用,与充心力竭的报告有一定"}, {"probability": {"variance": 0.022777, "average": 0.910719, "min": 0.425601}, "location": {"width": 1066, "top": 1349, "height": 61, "left": 322}, "words": "的相关性,日剂量400ag自发报告的心力衰竭发生率高于低剂量者,显小力衰发生的风险"}, {"probability": {"variance": 4.1e-05, "average": 0.994966, "min": 0.973792}, "location": {"width": 383, "top": 1418, "height": 41, "left": 324}, "words": "可能会随本品日剂量的增加而升高"}, {"probability": {"variance": 0.006097, "average": 0.965161, "min": 0.645655}, "location": {"width": 1016, "top": 1450, "height": 59, "left": 374}, "words": "伊曲康唑不应用于患有充血性心力衰竭或有充血性心力衰竭病史的患者,除非利明显大于"}, {"probability": {"variance": 0.00128, "average": 0.983827, "min": 0.842566}, "location": {"width": 1016, "top": 1500, "height": 59, "left": 374}, "words": "弊。对个体的利弊评估应考虑到的因素有病症的严重程度、给药方式和充血性心力衰竭的个"}, {"probability": {"variance": 0.026631, "average": 0.922763, "min": 0.364789}, "location": {"width": 1016, "top": 1550, "height": 59, "left": 376}, "words": "体危险因素。这些危险因包括心脏疾病,如缺血性或瓣性心脏病:严重的游部疾病,如"}, {"probability": {"variance": 0.006231, "average": 0.971526, "min": 0.514679}, "location": {"width": 1016, "top": 1603, "height": 57, "left": 376}, "words": "慢性阻塞性肺病:肾功能衰竭和其它水肿性疾病。医生应告知此类患者有关充血性心力衰端"}, {"probability": {"variance": 0.003602, "average": 0.979023, "min": 0.656797}, "location": {"width": 1014, "top": 1653, "height": 57, "left": 376}, "words": "的体征和症状,并慎用药,且在治疗中监测其充血性心力衰竭的体征和症状。如果在治疗"}, {"probability": {"variance": 0.013663, "average": 0.949711, "min": 0.376535}, "location": {"width": 1016, "top": 1703, "height": 54, "left": 379}, "words": "中出现这些体和症状,则应停止伊曲康唑的治疗。钙通道阻滞剂具有负性肌力作用,从而"}, {"probability": {"variance": 0.015956, "average": 0.940706, "min": 0.443711}, "location": {"width": 1016, "top": 1751, "height": 57, "left": 376}, "words": "会加强伊曲康唑的这一潜在作用。此外,伊曲康唑可抑制钙通道阻滞剂的代谢,当含使用"}, {"probability": {"variance": 0.018758, "average": 0.933181, "min": 0.464115}, "location": {"width": 790, "top": 1804, "height": 54, "left": 376}, "words": "伊曲康唑和钙遭道阻满剂时发生充血性心力衰竭的风险升高,需加注意"}, {"probability": {"variance": 0, "average": 0.935417, "min": 0.935417}, "location": {"width": 38, "top": 1843, "height": 36, "left": 1377}, "words": "7"}, {"probability": {"variance": 0.000702, "average": 0.985823, "min": 0.926772}, "location": {"width": 157, "top": 1870, "height": 31, "left": 379}, "words": "药物相互作用"}, {"probability": {"variance": 0.01406, "average": 0.951545, "min": 0.457925}, "location": {"width": 1009, "top": 1900, "height": 54, "left": 386}, "words": "本品有发生药物相互作用的可能性4参见[药物相互作用]项),这些相互作用可能具有临床"}, {"probability": {"variance": 0.045125, "average": 0.742594, "min": 0.362731}, "location": {"width": 205, "top": 1941, "height": 43, "left": 1201}, "words": "管庄用章"}, {"probability": {"variance": 2.1e-05, "average": 0.994518, "min": 0.98992}, "location": {"width": 52, "top": 1973, "height": 27, "left": 333}, "words": "意义"}, {"probability": {"variance": 0.002107, "average": 0.896536, "min": 0.850632}, "location": {"width": 34, "top": 1994, "height": 36, "left": 1299}, "words": "5)"}, {"probability": {"variance": 0.04984, "average": 0.684975, "min": 0.418019}, "location": {"width": 141, "top": 2131, "height": 52, "left": 1418}, "words": "仗供存"}], "language": 3}